{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:23:49Z","timestamp":1789662229070,"version":"4.0.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":164,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National University Complex for Biomedical and Applied Research","award":["D01-371\/15.12.2023"],"award-info":[{"award-number":["D01-371\/15.12.2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Monitoring the blood serum activity of L-asparaginase in children with acute lymphoblastic leukaemia (ALL) has been highly recommended to detect enzyme inactivation that can cause relapse and to avoid unwanted toxicity. Nevertheless, perhaps at least partially due to the lack of clinically approved commercially available kits or standardized and independently reproduced and validated in-house protocols, laboratory assay-based determination of the optimal doses of L-asparaginase is not carried out routinely. In this study, we adapted previously published protocols for two plate reader-based colorimetric methods, indooxine and Nessler, to measure asparaginase activity. Mock samples with dilutions of the enzyme for initial optimization steps, and patient samples were used as a proof of principle and to compare the two protocols. For the first time the indooxine and the Nessler methods are adapted for a plate reader and L-asparaginase serum activity levels are compared by both protocols. Passing\u2013Bablok and Bland\u2013Altman\u2019s statistical analyses found very little difference, strong correlation (r\u2009=\u20090.852), and bias of only 6% between the data from the two methods when used for fresh patient samples. Furthermore, we demonstrate that the Nessler method could also be applied for frozen sera as the results, compared to fresh samples, showed little difference, strong correlation (r\u2009=\u20090.817), and small bias (9%). We successfully adapted and validated two methods for measuring L-asparaginase activity in cALL and provided the most detailed description to date on how to reproduce and implement them in other clinical laboratories.<\/jats:p>","DOI":"10.1093\/biomethods\/bpae042","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:51:35Z","timestamp":1718365895000},"source":"Crossref","is-referenced-by-count":3,"title":["Implementation of plate reader-based indooxine and Nessler protocols for monitoring L-asparaginase serum activity in childhood acute lymphoblastic leukaemia"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9275-703X","authenticated-orcid":false,"given":"Bozhidar","family":"Vergov","sequence":"first","affiliation":[{"name":"Department of Medical Biology, Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]},{"name":"Research Institute at Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-3773","authenticated-orcid":false,"given":"Yordan","family":"Sbirkov","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]},{"name":"Research Institute at Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danail","family":"Minchev","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy and Physiology, University of Plovdiv \u2018Paisii Hilendarski\u2019 , 24 Tzar Asen St , Plovdiv 4000,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Todorova","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]},{"name":"Research Institute at Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Baldzhieva","sequence":"additional","affiliation":[{"name":"Research Institute at Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]},{"name":"Department of Medical Microbiology and Immunology \u2018Prof. Dr Elissay Yanev\u2019, Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Burnusuzov","sequence":"additional","affiliation":[{"name":"Research Institute at Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]},{"name":"Department of Pediatrics, Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]},{"name":"Pediatric Clinic, St George University Hospital , Plovdiv 4000,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u041cariya I","family":"Spasova","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sarafian","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]},{"name":"Research Institute at Medical University of Plovdiv , Plovdiv 4000,","place":["Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"2024111307481812300_bpae042-B1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/533452a","article-title":"1,500 scientists lift the lid on reproducibility","volume":"533","author":"Baker","year":"2016","journal-title":"Nature"},{"key":"2024111307481812300_bpae042-B2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/08989621.2016.1257387","article-title":"Reproducibility and Research Integrity","volume":"24","author":"Resnik","year":"2017","journal-title":"Account Res"},{"key":"2024111307481812300_bpae042-B3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature11556","article-title":"A call for transparent reporting to optimize the predictive value of preclinical research","volume":"490","author":"Landis","year":"2012","journal-title":"Nature"},{"key":"2024111307481812300_bpae042-B4","doi-asserted-by":"crossref","first-page":"e1002165","DOI":"10.1371\/journal.pbio.1002165","article-title":"The economics of reproducibility in preclinical research","volume":"13","author":"Freedman","year":"2015","journal-title":"PLoS Biol"},{"key":"2024111307481812300_bpae042-B5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2024111307481812300_bpae042-B6","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1002\/cncr.31669","article-title":"Toward the potential cure of leukemias in the next decade","volume":"124","author":"Kantarjian","year":"2018","journal-title":"Cancer"},{"key":"2024111307481812300_bpae042-B7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","article-title":"Use of L-asparaginase in childhood ALL","volume":"28","author":"Muller","year":"1998","journal-title":"Crit Rev Oncol Hematol"},{"key":"2024111307481812300_bpae042-B8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1043454212471728","article-title":"Managing hypersensitivity to asparaginase in pediatrics, adolescents, and young adults","volume":"30","author":"Shinnick","year":"2013","journal-title":"J Pediatr Oncol Nurs"},{"key":"2024111307481812300_bpae042-B9","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3109\/10428194.2010.494316","article-title":"Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia","volume":"51","author":"Strullu","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"2024111307481812300_bpae042-B10","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1002\/cncr.29641","article-title":"Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: a children's oncology group report","volume":"121","author":"Ko","year":"2015","journal-title":"Cancer"},{"key":"2024111307481812300_bpae042-B11","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2012.43.2070","article-title":"Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study\u2014Dana-Farber Cancer Institute ALL Consortium Protocol 00-01","volume":"31","author":"Vrooman","year":"2013","journal-title":"J Clin Oncol"},{"key":"2024111307481812300_bpae042-B12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3109\/10428194.2014.1003056","article-title":"Asparaginase pharmacokinetics and implications of therapeutic drug monitoring","volume":"56","author":"Asselin","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"2024111307481812300_bpae042-B13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/pbc.25299","article-title":"Clinical application of asparaginase activity levels following treatment with pegaspargase","volume":"62","author":"Bleyer","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2024111307481812300_bpae042-B14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.blre.2017.06.002","article-title":"Catalyzing improvements in ALL therapy with asparaginase","volume":"31","author":"Marini","year":"2017","journal-title":"Blood Rev"},{"key":"2024111307481812300_bpae042-B15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3324\/haematol.2015.137380","article-title":"Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation","volume":"101","author":"van der Sluis","year":"2016","journal-title":"Haematologica"},{"key":"2024111307481812300_bpae042-B16","first-page":"55","article-title":"Monitoring the asparaginase activity and asparagine levels in children with acute lymphoblastic leukaemia treated with different as-paraginase preparations","volume":"2","author":"Kone\u010dn\u00e1","year":"2004","journal-title":"Scripta Medica (Brno)"},{"key":"2024111307481812300_bpae042-B17","doi-asserted-by":"crossref","first-page":"e26686","DOI":"10.1002\/pbc.26686","article-title":"Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation","volume":"64","author":"Tram Henriksen","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"2024111307481812300_bpae042-B18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/bjh.12865","article-title":"Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia","volume":"166","author":"Henriksen","year":"2014","journal-title":"Br J Haematol"},{"key":"2024111307481812300_bpae042-B19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002800100286","article-title":"Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration","volume":"48","author":"Albertsen","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"2024111307481812300_bpae042-B20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1008368916800","article-title":"L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure","volume":"11","author":"Rizzari","year":"2000","journal-title":"Ann Oncol"},{"key":"2024111307481812300_bpae042-B21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0003-2697(02)00232-4","article-title":"Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum","volume":"309","author":"Lanvers","year":"2002","journal-title":"Anal Biochem"},{"key":"2024111307481812300_bpae042-B22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/pbc.22417","article-title":"Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007","volume":"54","author":"Schrey","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"2024111307481812300_bpae042-B23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/FTD.0000000000000472","article-title":"Therapeutic drug monitoring of asparaginase activity-method comparison of MAAT and AHA test used in the international AIEOP-BFM ALL 2009 trial","volume":"40","author":"Lanvers-Kaminsky","year":"2018","journal-title":"Ther Drug Monit"},{"key":"2024111307481812300_bpae042-B24","doi-asserted-by":"crossref","first-page":"21481","DOI":"10.1038\/s41598-020-78549-y","article-title":"Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center","volume":"10","author":"Cecconello","year":"2020","journal-title":"Sci Rep"},{"key":"2024111307481812300_bpae042-B25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08880018.2018.1538277","article-title":"Experience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity","volume":"35","author":"Vyas","year":"2018","journal-title":"Pediatr Hematol Oncol"},{"key":"2024111307481812300_bpae042-B26","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/bcp.14216","article-title":"A comparison of asparaginase activity in generic formulations of E.coli derived L- asparaginase: in-vitro study and retrospective analysis of asparaginase monitoring in pediatric patients with leukemia","volume":"86","author":"Sankaran","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"2024111307481812300_bpae042-B27","first-page":"709","article-title":"A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I","volume":"21","author":"Passing H. Bablok","year":"1983","journal-title":"J Clin Chem Clin Biochem"},{"key":"2024111307481812300_bpae042-B28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"2024111307481812300_bpae042-B29","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0021-9258(19)42886-X","article-title":"Substrate binding and intersubunit interactions in L-asparaginase","volume":"249","author":"Shifrin","year":"1974","journal-title":"J Biol Chem"},{"key":"2024111307481812300_bpae042-B30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11613\/BM.2011.010","article-title":"Comparison of methods: passing and Bablok regression","volume":"21","author":"Bilic-Zulle","year":"2011","journal-title":"Biochem Med (Zagreb)"},{"key":"2024111307481812300_bpae042-B31","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the children's oncology group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol"},{"key":"2024111307481812300_bpae042-B32","doi-asserted-by":"crossref","first-page":"e1729","DOI":"10.1002\/cnr2.1729","article-title":"Asparaginase activity monitoring in pediatric acute lymphoblastic leukemia: a cross-sectional nationwide study in Spain","volume":"6","author":"Lassaletta","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"2024111307481812300_bpae042-B33","first-page":"282","article-title":"Monitoring of treatment with L-asparaginase in children with acute lymphoblastic leukaemia, with a focus on silent inactivation and its influence on the treatment outcome","volume":"26","author":"Czogala","year":"2022","journal-title":"Contemp Oncol (Pozn)"},{"key":"2024111307481812300_bpae042-B34","first-page":"1160","article-title":"Our experiences with asparaginase activity measurements in children with lymphoblastic diseases","volume":"10","author":"Muller","year":"2023","journal-title":"Children (Basel)"},{"key":"2024111307481812300_bpae042-B35","first-page":"65","article-title":"Monitoring asparaginase activity to improve the management of patients with acute lymphoblastic leukemia: experience in one center","volume":"100","author":"Garcia Morin","year":"2024","journal-title":"An Pediatr (Engl Ed)"},{"key":"2024111307481812300_bpae042-B36","author":"van Maanen","year":"2014"},{"key":"2024111307481812300_bpae042-B37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/diagnostics14060623","article-title":"Determination of l-asparaginase activity and its therapeutic monitoring in children with hematological malignancies in a single croatian center","volume":"14","author":"Lenicek Krleza","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"2024111307481812300_bpae042-B38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11613\/BM.2015.015","article-title":"Understanding bland altman analysis","volume":"25","author":"Giavarina","year":"2015","journal-title":"Biochem Med (Zagreb)"},{"key":"2024111307481812300_bpae042-B39","doi-asserted-by":"crossref","first-page":"bio055020","DOI":"10.1242\/bio.055020","article-title":"Stability of amino acids and related amines in human serum under different preprocessing and pre-storage conditions based on iTRAQ((R))-LC-MS\/MS","volume":"10","author":"An","year":"2021","journal-title":"Biol Open"},{"key":"2024111307481812300_bpae042-B40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1515\/folmed-2017-0090","article-title":"Treatment of childhood acute myeloid leukemia in Bulgaria","volume":"60","author":"Burnusuzov","year":"2018","journal-title":"Folia Med (Plovdiv)"},{"key":"2024111307481812300_bpae042-B41","doi-asserted-by":"crossref","first-page":"100651","DOI":"10.1016\/j.blre.2020.100651","article-title":"Critical overview of the main features and techniques used for the evaluation of the clinical applicability of L-asparaginase as a biopharmaceutical to treat blood cancer","volume":"43","author":"Costa-Silva","year":"2020","journal-title":"Blood Rev"},{"key":"2024111307481812300_bpae042-B42","doi-asserted-by":"crossref","first-page":"116723","DOI":"10.1016\/j.watres.2020.116723","article-title":"Hydroxylamine and the nitrogen cycle: a review","volume":"190","author":"Soler-Jofra","year":"2021","journal-title":"Water Res"},{"key":"2024111307481812300_bpae042-B43","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0959-8049(96)00131-1","article-title":"Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations","volume":"32A","author":"Boos","year":"1996","journal-title":"Eur J Cancer"},{"key":"2024111307481812300_bpae042-B44","first-page":"512","volume-title":"Acute Leukemias VI. Haematology and Blood Transfusion\/H\u00e4matologie Und Bluttransfusion","author":"Werber","year":"1997"},{"key":"2024111307481812300_bpae042-B45","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2006-07-035006","article-title":"Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia","volume":"109","author":"Douer","year":"2007","journal-title":"Blood"},{"key":"2024111307481812300_bpae042-B46","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-200544040-00003","article-title":"Pharmacokinetic\/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future","volume":"44","author":"Avramis","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"2024111307481812300_bpae042-B47","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1007\/s00216-018-1326-x","article-title":"A critical analysis of L-asparaginase activity quantification methods-colorimetric methods versus high-performance liquid chromatography","volume":"410","author":"Magri","year":"2018","journal-title":"Anal Bioanal Chem"},{"key":"2024111307481812300_bpae042-B48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2015.08.042","article-title":"An analytical quality by design (aQbD) approach for a L-asparaginase activity method","volume":"117","author":"Yao","year":"2016","journal-title":"J Pharm Biomed Anal"}],"container-title":["Biology Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomethods\/advance-article-pdf\/doi\/10.1093\/biomethods\/bpae042\/58230233\/bpae042.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/9\/1\/bpae042\/60635831\/bpae042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/9\/1\/bpae042\/60635831\/bpae042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T10:56:50Z","timestamp":1731495410000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomethods\/article\/doi\/10.1093\/biomethods\/bpae042\/7693052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,11]]}},"URL":"https:\/\/doi.org\/10.1093\/biomethods\/bpae042","relation":{},"ISSN":["2396-8923"],"issn-type":[{"value":"2396-8923","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"bpae042"}}